Gjennom vår egen forskning har vi identifisert isolater som blir brukt for å utvikle en ny vaksine, jobber med å bestemme reservoarer, overlevelse av bakterier i sjøvann, screening av stamfisk og testing flere vaksinasjonsstrategier samt QTL for SRS.

CHILE - A group of salmon farming companies in Chile have started a joint effort specifically aimed at helping the industry reduce its antibiotic use.

Major salmon farmer Cermaq has announced that it will be conducting further tests on a new Pharmaq live vaccine for salmon rickettsial septicaemia (SRS) alongside other existing SRS vaccines in an ongoing effort by the company to reduce mortality rates of Chilean farmed salmon.

I et forsøk på å redusere volumet av antibiotika som brukes til å bekjempe SRS i Chile, har et ny felles initiativ kalt prosjekt Pincoy, blitt lansert av Skretting, Aquagen/Blue Genomics, Pharmaq, Centrovet, Cermaq, Blumar og Ventisqueros.

Chile's salmon industry, the second-largest in the world, is trying to cut back its heavy use of antibiotics, which pollute the environment and could cause new super-bacteria to emerge.

The Pincoy program was designed for companies operating in different cycles of the salmon industry to combine expertise and come up with solutions to combat salmonid rickettsial syndrome (SRS) and the industry’s other big challenges, Skretting country manager Ronald Barlow said in a statement.

The reduction of antibiotic use in salmon production by half over a two-year span is the main aim of a new project just undertaken by a subset of Chile’s aquaculture sector.

Several companies linked to the Chilean salmon farming industry in Puerto Montt presented a project to reduce antibiotics use in the sector, a practice that for a while now has generated strong opposition from environmental organizations worldwide.

Chile’s salmon industry will invest a combined $58 million to reduce antibiotics usage by half in the next two years, the companies said.

In a bid to reduce the volume of antibiotics used to combat SRS in Chile, a new joint initiative, called Project Pincoy, has been launched by Skretting, Aquagen/Blue Genomics, Pharmaq, Centrovet, Cermaq, Blumar and Ventisqueros.